Literature DB >> 17174591

Chemical genetic approaches to probing cell death.

Nidhi M Gangadhar1, Brent R Stockwell.   

Abstract

Chemical genetics has arisen as a tool for the discovery of pathways and proteins in mammalian systems. This approach, comprising small-molecule screening combined with biochemical and genomic target identification methods, enables one to assess which proteins are involved in regulating a particular phenotype. Applied to cell death, this strategy can reveal novel targets and pathways regulating the demise of mammalian cells. Numerous diseases have been linked to the loss of regulation of cell death. Defining the mechanisms governing cell death in these diseases might lead to the discovery of therapeutic agents and targets and provide a richer understanding of the mortality of living systems. Recent advances include the discovery of novel small molecules regulating cell death pathways -- necrostatin and erastin -- as well as the elucidation of the mechanism of death induced in cancer cells by the cytotoxic agent Apratoxin A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174591      PMCID: PMC3057070          DOI: 10.1016/j.cbpa.2006.11.033

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  43 in total

Review 1.  The Fas signaling pathway: more than a paradigm.

Authors:  Harald Wajant
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.

Authors:  Sonam Dolma; Stephen L Lessnick; William C Hahn; Brent R Stockwell
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

Review 3.  The chemical biology of apoptosis. Exploring protein-protein interactions and the life and death of cells with small molecules.

Authors:  Ziwei Huang
Journal:  Chem Biol       Date:  2002-10

4.  Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp.

Authors:  Philip G Williams; Wesley Y Yoshida; Richard E Moore; Valerie J Paul
Journal:  J Nat Prod       Date:  2002-09       Impact factor: 4.050

5.  Structure-activity relationship study of novel necroptosis inhibitors.

Authors:  Xin Teng; Alexei Degterev; Prakash Jagtap; Xuechao Xing; Sungwoon Choi; Régine Denu; Junying Yuan; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2005-11-15       Impact factor: 2.823

6.  Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).

Authors:  Madeleine Duvic; Rakshandra Talpur; Xiao Ni; Chunlei Zhang; Parul Hazarika; Cecilia Kelly; Judy H Chiao; John F Reilly; Justin L Ricker; Victoria M Richon; Stanley R Frankel
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

Review 7.  Genome-scale loss-of-function screening with a lentiviral RNAi library.

Authors:  David E Root; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

Review 8.  Histone deacetylase inhibitors as new cancer drugs.

Authors:  P A Marks; V M Richon; R Breslow; R A Rifkind
Journal:  Curr Opin Oncol       Date:  2001-11       Impact factor: 3.645

9.  Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.

Authors:  H Luesch; W Y Yoshida; R E Moore; V J Paul; T H Corbett
Journal:  J Am Chem Soc       Date:  2001-06-13       Impact factor: 15.419

10.  Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.

Authors:  R Furumai; Y Komatsu; N Nishino; S Khochbin; M Yoshida; S Horinouchi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  9 in total

1.  The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization.

Authors:  Konjeti R Sekhar; Yerramreddy Thirupathi Reddy; Penthala Narsimha Reddy; Peter A Crooks; Amudhan Venkateswaran; William Hayes McDonald; Ling Geng; Soumya Sasi; Robert P Van Der Waal; Joseph L Roti Roti; Kenneth J Salleng; Girish Rachakonda; Michael L Freeman
Journal:  Clin Cancer Res       Date:  2011-08-30       Impact factor: 12.531

2.  Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.

Authors:  L A Bateman; T B Nguyen; A M Roberts; D K Miyamoto; W-M Ku; T R Huffman; Y Petri; M J Heslin; C M Contreras; C F Skibola; J A Olzmann; D K Nomura
Journal:  Chem Commun (Camb)       Date:  2017-06-29       Impact factor: 6.222

Review 3.  The Chemistry and Biology of Ferroptosis.

Authors:  Brent R Stockwell; Xuejun Jiang
Journal:  Cell Chem Biol       Date:  2020-04-16       Impact factor: 8.116

4.  Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature.

Authors:  Ling Geng; Girish Rachakonda; D James Morré; Dorothy M Morré; Peter A Crooks; Vijayakumar N Sonar; Joseph L Roti Roti; Buck E Rogers; Suellen Greco; Fei Ye; Kenneth J Salleng; Soumya Sasi; Michael L Freeman; Konjeti R Sekhar
Journal:  FASEB J       Date:  2009-04-24       Impact factor: 5.191

5.  Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity.

Authors:  Kimberly E Anderson; Milton To; James A Olzmann; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2017-09-13       Impact factor: 5.100

6.  Enantioselective synthesis of 3-arylquinazolin-4(3H)-ones via peptide-catalyzed atroposelective bromination.

Authors:  Matthew E Diener; Anthony J Metrano; Shuhei Kusano; Scott J Miller
Journal:  J Am Chem Soc       Date:  2015-09-18       Impact factor: 15.419

7.  A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.

Authors:  Fabiana A Serrano; Alisson L Matsuo; Priscila T Monteforte; Alexandre Bechara; Soraya S Smaili; Débora P Santana; Tiago Rodrigues; Felipe V Pereira; Luis S Silva; Joel Machado; Edson L Santos; João B Pesquero; Rafael M Martins; Luiz R Travassos; Antonio C F Caires; Elaine G Rodrigues
Journal:  BMC Cancer       Date:  2011-07-14       Impact factor: 4.430

8.  The yeast three-hybrid system as an experimental platform to identify proteins interacting with small signaling molecules in plant cells: potential and limitations.

Authors:  Stéphanie Cottier; Timon Mönig; Zheming Wang; Jiří Svoboda; Wilhelm Boland; Markus Kaiser; Erich Kombrink
Journal:  Front Plant Sci       Date:  2011-12-26       Impact factor: 5.753

9.  Brønsted acid-catalysed enantioselective construction of axially chiral arylquinazolinones.

Authors:  Yong-Bin Wang; Sheng-Cai Zheng; Yu-Mei Hu; Bin Tan
Journal:  Nat Commun       Date:  2017-05-19       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.